The streams for veterinary nurses will include six lectures on topics ranging from neurology to dentistry, along with guest speaker Hannah Donovan from Donovan Veterinary Behaviour to discuss behaviour in practice.
There will also be a speaker from Davies’ charity of the year: Vetlife.
Davies' hospital director Ben Orton said: “This is a high-level CPD and networking event aimed at our colleagues in the veterinary industry with a raft of advice and insight from some of the leading specialists here at Davies.
“Some of the topics covered include internal medicine, with EBVS European specialist in small animal internal medicine Katherine Clarke giving her expert opinion on chronic enteropathies with a focus on antibiotic prescribing.
“Head of anaesthesia Frances Downing will focus on anaesthesia and feline cardiomyopathies while head of physiotherapy Diane Messum will discuss a holistic approach to the osteoarthritis patient, so there will be plenty of stimulating and challenging content.”
The day-long event begins at 8.30am with arrival drinks and pastries before the morning session, which runs from 9am to 1.20pm.'
After an hour’s break for lunch and networking, the afternoon session will run from 2.20pm to 5pm.
That will be followed by a complimentary hog roast.
www.vetspecialists.co.uk/davies-congress-2024
The webinars cover a range of clinical topics, including evaluating Brachycephalic Obstructive Airway Syndrome (BOAS), cognitive decline in senior dogs, cannabinoid therapy, feline weight loss, corneal ulcers and seizure management.
Vet and Tech says the 10-session series features speakers from top veterinary institutions.
The webinars are available both both live and on-demand.
https://www.vetandtech.com/webinars
The authors say that whilst it has long been suspected that adverse drug reactions are under-reported, this study is the first to show the scale of the problem, using real data from veterinary clinical records.
For the study, researchers looked for electronic heath records within the Small Animal Veterinary Surveillance Network (SAVSNET) which contained “adverse drug reactions” and “side effects” in the free-text clinical narratives.
The results were then analysed to determine the suspected product, the seriousness and expectedness of the event, and whether the event had been reported to the Veterinary Medicines Directorate or Marketing Authorisation Holders.
Of the 827 cases of suspected adverse drug reactions identified out of a total of 10,565 records reviewed, approximately 90% were not reported.
74% were related to dogs and 70% were listed as “expected” (i.e. already listed in the product information).
The clinical severity of the reaction didn’t appear to impact whether it was reported.
Dr Heather Davies, lead author of the study, said: “As adverse drug reaction reporting rate is directly linked to the regulators ability to mitigate safety issues, this paper is a call to arms encouraging all veterinary professionals to report suspected adverse drug reactions and regulators to make reporting quicker and easier.
"It also the highlights the promise that big real-world data sets hold in enhancing drug safety monitoring processes.”
https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13721
The full BEVA Congress programme is now live and super early bird tickets are available from 4th March, saving member delegates up to £200.
The one medicine thread will run through the medicine and orthopaedics and sports medicine streams as well as feature in the Peter Rossdale Plenary Lecture.
BEVA President Roger Smith said “There is much to learn from the human side as well as from what we do as vets.
"We have invited five human medical experts to make some comparative links with human medicine in their presentations.
"Bringing a different angle in this way will help predict what the future holds and advance what we do in the equine veterinary sphere.”
The full programme includes more than 90 hours of live and on-demand CPD covering almost every aspect of equine medicine, surgery and practice.
The first day will commence with an opening address from Olympic gold medallist Sally Gunnell during which she will share her thoughts on maximising performance.
Other highlights include:
Individual super early bird BEVA members prices are £524 for vets and £144 for vet nurses for all three days (with concessionary available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Super early bird ends on Wednesday 29 May 2024.
www.bevacongress.org
Dr Mark Johnston, CEO of Vetstream said: “The usage data of Vetlexicon has continually shown us how important the client factsheets are to practices helping clients understand the health and welfare of their animals.
"Whilst most of our subscribers are accepting of the Vetlexicon content in English, the preferred language of many pet owners is not necessarily English, and we wanted to help practices with that.
"So a major new dimension to the new Vetlexicon website is to enable the content to be made available in many European and Asian languages so that when you are viewing a client factsheet, you can instantly see that content in Spanish, French or Korean and then print it out on paper and give to the owners for them to share with friends or family on their return to home; or to print it as a PDF and email it to them.
"Practices have told us that this will be so useful for the relationship with their clients, and so it is great to be able to provide that now.”
The company says it has also improved the interface and functionality of the site and made it mobile phone friendly.
www.vetlexicon.com
The centres have cutting-edge facilities, including high-tech audio-visual equipment with ceiling-mounted cameras to relay demonstrations, phantom models for abdominal ultrasound training and advanced simulators for practicing echocardiography.
The courses will be taught mainly by clinicians from across the IVC Evidensia network,
IVC says the centres will deliver 20,000 hours of CPD for its staff this year, and it aims to make its training available to the broader veterinary community towards the end of 2025.
Daniella Dos Santos, Director of Professional Culture at IVC Evidensia, said: “These centres will allow us to provide tailored training, whether you’re just starting your career or you’re looking to develop new skills and techniques.
"The training will help us deliver exceptional care for pets and their owners by ensuring our colleagues and eventually the wider profession continue to grow and develop their expertise.”
Available in packs of 56 (4 x 14 tablet blister packs), Lodisure tablets are divisible for accurate dosing.
The recommended starting dose is 0.125-0.25 mg amlodipine per kg bodyweight per day, which equates to half a tablet for cats weighing less than 4kg (and more than 2kg) and one tablet per day for cats weighing between 4kg and 8kg.
It can be administered directly to the cat or given with a small quantity of food.
Dechra companion animal brand manager, Sarah Musgrave, said: “Feline hypertension is very often part of a more complex diagnosis, therefore it is important that antihypertensive therapies are easy to dose and administer.
"Lodisure is a new, first-line, easy to dose and administer treatment to control systolic blood pressure in cats while the underlying primary cause is diagnosed and treated, which vets can rely on in their day-to-day practice.”
https://www.dechra.co.uk/products/cat/prescription/lodisure.
The opening speaker will be Cassie Leonard (pictured), engineer, best-selling author and executive coach, who will be talking about the value of authentic networking.
The programme, which includes a combination of lectures, panel sessions and interactive workshops, will cover:
On the Saturday, there's a dedicated ‘Grow your business’ day for those thinking of starting up or expanding their business.
New for 2025 will be a Friday morning collaborative ‘Business Club Live’ speed-networking session: an opportunity to discuss a variety of issues on hosted tables.
Also new for 2025 will be a dedicated livestock stream focussing on the unique challenges faced by livestock veterinary professionals.
The accompanying exhibition will host a selection of companies focussed on the business, management, marketing and client-facing aspects of veterinary practice and offering the latest products, services and advice.
Social events include Thursday afternoon's Happy Hour followed by a networking event and Friday night’s Presidents’ party with a reception, 3-course meal and a performance by the party band The Kings.
www.spvs-congress.co.uk
The company says that Daxocox achieves significant improvement of clinical signs associated with the pain of osteoarthritis (OA) in dogs1,2 and also helps reduce the risk of breakthrough pain.
Breakthrough pain is defined as “an abrupt, short-lived, and intense pain that breaks through the analgesia that controls pain”3. Risk factors for breakthrough pain in cases of canine OA include poor owner compliance, variable plasma drug levels between doses, natural or exercise induced flare-ups and disease progression.
According to research carried out by the company, veterinary surgeons estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain4, whilst owners put the figure much higher at 80%5.
Animalcare says that as well as compromising patient welfare and increasing the risk of clinical consequences such as wind-up pain (hypersensitisation), breakthrough pain risks owners losing confidence in their vet and/or the recommended treatment plan for their dog. This may lead owners to independently stray from the treatment plan, with potentially damaging consequences. In its research, 87% of vets agreed that avoiding breakthrough pain is critical to the management of canine OA4.
Animalcare adds that because of the pharmacology, there is no risk of risk of over-accumulation or need for mandatory treatment ‘breaks’6. Also, adverse effects were found to be no different from any other NSAID1,2 and there was no increase in treatment-related adverse effects at up to 5 times the recommended dose7, so Daxocox has a broad margin of safety and is well tolerated by dogs7.
James Beaumont, marketing manager at Animalcare said: “Daxocox’s weekly administration of a flavoured tablet addresses some of the challenges of managing canine OA that I’m certain most vets will identify with. Breakthrough pain is a real problem and by being able to provide consistent pain control, in a compliance friendly formulation, Daxocox is a real game changer for canine OA management.
For more information, visit: www.animalcare.co.uk, or contact your local Animalcare territory manager, or Animalcare’s head office on 01904 487687.
References:
Zoetis has announced a supply problem with Equip Artervac, its vaccine against equine viral arteritis
The current inventory of Equip Artervac has an expiry date of March 29, 2023 and the company is not expecting a new batch to be available until the end of September 2023.
Zoetis says it has been working with relevant organisations to implement a plan to mitigate the impact on breeders.
The Thoroughbred Breeders Association has published advice for a blood sampling scheme at: https://www.rossdales.com/news-events/tba-members-equine-vaccine-advice-regarding-disruption-to-supply-of-equip-artervac, but Zoetis highlights that the advice requires action two weeks after the most recent EVA vaccination.
For more information contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0345 300 8034
The three companies will now offer their services, which include marketing strategy, brand management, search engine marketing, online advertising, email marketing, webchat, social media copywriting, graphic design and web design under the VetsDigital brand.
Sarah Spinks, Managing Director of VetsDigital, said: "In the pursuit of better animal welfare, we empower animal owners, and bridge the gap between the veterinary professional and the pet parent using the most effective digital channels.
“As one combined company, we become Europe’s leading digital agency that specialises in the veterinary sector. With our current presence in 11 countries, we’ll be able to further develop our network whilst still providing our clients with the same personal service they’ve come to expect and deserve.”
Marcelo Alves, Managing Director of Vet Inflow, will move into the role of Managing Partner for Portugal and Spain at VetsDigital, as the company expands to have bases in both the UK and Portugal.
Will Stirling, who becomes a Managing Partner at VetsDigital, bringing with him 14 years of experience marketing in the veterinary industry, having previously worked with veterinary group YourVets and CVS, said: "The veterinary industry is buzzing with growth and renewal as many parts of veterinary marketing and management move into the digital realm. It’s the perfect time to combine the talents of our 3 teams, so that together we can offer industry-leading digital marketing services to veterinary businesses across the UK and Europe.
For more information, visit: https://vetsdigital.com
Vet-AI's automated triage app offers instant advice to pet owners 24/7, early detection of health issues and advice as to whether they need to speak to a vet.
For the blinded test, which was conducted in April 2025, three UK veterinary surgeons reviewed the responses from Vet-AI, Gemini 2.0 and ChatGPT 4.0 to 48 simulated enquiries from owners.
The vets evaluated each on clinical accuracy, triage effectiveness and the subjective criteria of factuality, integrity, safety, empathy and readability.
Vet-AI’s Large Language Model (LLM) achieved an accuracy score of 81%, surpassing Gemini (69%) and ChatGPT (50%).
Vet-AI’s model also stopped triage at the correct point in 81% of cases according to the vets, compared with Gemini’s 75% and ChatGPT’s 56%.
Vet-AI’s tool also outperformed the leading LLMs on subjective measures, delivering more empathetic, thorough and factual responses to pet owners.
Samantha Webster, Chief Veterinary Officer at Vet-AI said: “These latest results are a significant milestone in the development of automated triage.
"We’re proving we can provide trustworthy online pet care by combining clinical and technical expertise.
"This tool can support the wider industry too, engaging more pet owners in the first step of vet care, ensuring their pets get the care they need - whether in practice or remotely.
"We know that an increasing percentage of the UK pet population is struggling to access veterinary care.
"Whilst AI will never replace a vet, the use of innovative technology can break down the barrier to access, leading to more pets getting the care they need, when they need it."
“With this level of clinical accuracy and technical innovation, we're helping to bring great pet care to more people. As well as helping to create more demand for vet services by making the triage of pets as accurate as possible,” said Paul Hallett, Vet-AI founder and exec chair.
https://www.vet-ai.com/automated-triage
Omniflora paste is designed to provide fast acting support in acute digestive upset or strategically ahead of perceived stressful events such as travel or veterinary appointments.
It contains probiotics, prebiotics, adsorbents, parabiotics, postbiotics, electrolytes and nutrients.
Omniflora tablets are available for animals who resist an oral syringe.
The tablets contain probiotics, prebiotics and adsorbent clay and fibre.
Veterinary nurse and sales manager, Tara Evans, said: “Digestive upset in cats and dogs is common.
"We wanted to provide vets and pet owners with an easy-to-use solution that can be used in practice or at home.
"One tube of paste lasts for three consecutive days to support cats and dogs as they recover from gastrointestinal upset.”
"As well as supporting the gut in acute episodes of digestive upset such as diarrhoea, Omniflora can be used ahead of time in stressful events such as travelling, visiting the groomers, or any planned veterinary procedures such as surgeries or blood tests.”
Omniflora can be ordered here https://www.vitaanimalhealth.com/product/omniflora
Reasonable adjustments can include changing working arrangements and providing equipment, services and support.
The campaign will address common myths and misconceptions surrounding reasonable adjustments and highlight the legal obligations of leaders and managers around implementation.
The campaign, which will run until the end of July, is being launched after an RCVS/British Veterinary Chronic Illness Support (BCVIS) survey concluded there is a need to increase awareness about reasonable adjustments, promote wider discussion and equip organisations with the information they need to implement them.
The research also indicated that improved knowledge of legislation is needed, with communication also being raised as an important issue, so that individuals feel empowered to ask for the support they need.
MMI Lead, Rapinder Newton, said: “Our ‘Let’s talk adjustments’ campaign will support people to have these important conversations by sharing information, educational resources and guidance on good practice.
"It will also provide examples of different types of adjustments, including examples that are specific to the veterinary context.
“We know that physical and mental health are deeply interconnected.
"Reasonable adjustments can support both physical and mental health but also helps to safeguard mental health through allowing individuals with disabilities to thrive.
“We will be keeping people updated on the campaign, which has its own dedicated section on the RCVS website, via the RCVS social media channels, as well as providing information in RCVS newsletters, so do keep an eye out for this over the coming months.”
https://www.rcvs.org.uk/lifelong-learning/leadership-diversity-and-inclusion/reasonable-adjustments-campaign/
Photo courtesy: https://depositphotos.com
The webinars will be available as live podcasts and will also be able to be viewed on demand on the Dechra Academy.
In the strangles webinar, Dave Rendle, Gayle Hallowell and Richard Newton will explore the current landscape of strangles control, focusing on the role of vaccination, testing and quarantine measures.
In the disease prevention webinar, Gayle Hallowell, Dave Rendle, Tamzin Furtado and others will give an insight into chronic disease management and preventative vaccination to improve uptake and optimise treatment outcomes.
Both webinars broadcast from 8pm GMT, with a live Q&A session from 8:45pm, finishing at 9:15pm.
https://membership.elearning.vet/Dechra-equine-medicine-series.
All RVNs were set an email with a voting link and a unique voter code.
The College says it will be writing to the few veterinary nurses for whom it has no unique email address with further instructions.
There are 3 candidates standing this year and you can now cast your votes for up to two of them by 5pm on Friday 26 April 2024.
The candidates are:
The individual candidate profiles are available to view at www.rcvs.org.uk/vnvote24 where you can also read the candidates’ answers to two questions of their choice submitted by the profession.
The two candidates with the most votes will join VN Council for their three-year terms at the College’s AGM in July.
Any vet nurses who have not received their voting email should contact CES directly on support@cesvotes.com.
For the study, the RVC interviewed 13 small animal general practitioners, exploring their experience of providing pre-purchase consultations for brachycephalic dogs.
The study revealed a number of barriers to delivering effective pre-purchase consultations and advice about these breeds.
They included limited time and resources, competition for appointment availability, a perception that vets are only there to fix things, public distrust of veterinary surgeons (often over money), fear of damaging vet-client relationships, and the conflicting influence of breeders and the Kennel Club on clients.
Many veterinary surgeons that took part in the research felt that they had little or no power to overcome these barriers which are highly intractable at an individual veterinarian level.
A resulting moral conflict in veterinary surgeons between their perceived ethical and moral responsibilities to animal welfare versus the needs and wants of their clients and businesses was expressed by many vets in the study, and was felt to compromise their professional integrity and autonomy.
The study set out a series of recommendations:
Dr Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science at the RVC and lead author of the study, said: “This is the first time that the impact of brachycephaly on the practising veterinary surgeon has been explored.
"Our concerning results highlight the importance of recognising that the brachycephalic crisis is not only negatively impacting animals, but it is affecting human wellbeing too.
“Our study highlights the conflict that vets are experiencing - bound both by their duty of care to their brachycephalic patients, but also to animal welfare at a population level.
"Trying to balance both of these responsibilities in the current working environment is proving very challenging for some, leading to moral distress.
"It is, therefore, essential that we protect the mental wellbeing of vets on this issue as well as from an animal welfare perspective.
“As the brachycephalic crisis continues to prevail, the support of leading veterinary organisations is vital in providing a united voice regarding the known harms of brachycephaly and support in facilitating PPCs to ensure vets are protected, and potential owners are fully informed when it comes to acquiring decisions.”
Dr Dan O’Neill, Assoc Prof of Companion Animal Epidemiology at the RVC and co-author of the study, said:
“Over the past decade, the RVC has generated a vast evidence base revealing the true extent of the serious health issues of dogs with brachycephaly.
"This new study now focuses RVC research towards protecting the wellbeing of practising veterinary surgeons who are also shown as victims of the brachycephalic crisis.
"The clear message here is that we all need to ‘stop and think before buying a flat-faced dog’.”
The RCVS says this is the first time that two leading organisations in veterinary QI are collaborating to establish a new evidence-based model for QI specific to veterinary care.
The project is being overseen by Jocelyn Toner MRCVS, an experienced veterinary surgeon with a background in shelter medicine and an interest in evidence-based interventions to improve welfare outcomes.
The team will test the model against a prevalent problem in practice and measure the cost of making the changes against the benefit it brings.
They will refine the model based on lessons learned before they make it available to all veterinary practices, to tackle any area a practice wants to improve, regardless of practice type or specialism.
The aim is to help time-poor practitioners implement proven QI methods to improve outcomes and provide a return on investment.
Jocelyn said: “I’m looking forward to working with colleagues from across the sector to develop a model that will make Quality Improvement more accessible, and show that it can have a real economic benefit.
"We know that there is increased demand for veterinary teams to provide more efficient and effective care while maintaining high levels of animal welfare, improving team welfare and client satisfaction.
"Over recent years an increasing number of veterinary teams have embraced QI techniques.
"Now is the time to take this to the next level by creating an evidence-based model for QI, which can be applied systematically in any veterinary setting.
The project will involve bringing together veterinary professionals to co-design the model and test it in practice.
If you are interested in supporting this work, please register your interest at: rcvsknowledge.org.uk/forms/ktp-interest-form/
Amanda originally studied and worked in Australia where she undertook a residency in small animal medicine at Murdoch University, completing a Masters in respiratory medicine in dogs.
She moved to the UK in 2016 to work in referral medicine, joining Hamilton Specialist Referrals in 2024 as head of its medicine service.
The webinar will include a refresher on the bacterial, fungal, parasitic and protozoal causes of lower respiratory tract disease and its pathology, after which it will look at techniques and methods for diagnosis.
Amanda's presentation will also look at the secondary effects of infectious lower respiratory disease pathogens, and prescribing and management options.
The webinar is open to vets, veterinary nurses, students and support staff.
https://horiba.link/respiratory-disease-in-dogs-and-cats
The award categories are:
Nominations are welcome from both BSAVA members and non-members.
Nominations close on 30th October 2024 and the winners will be announced on 16th January 2025.
The BSAVA awards ceremony will take place at the reinvented Congress and Expo 2025, taking place at Manchester Central in March.
https://www.bsava.com/awards.
The ERP was established in 2016 when it emerged that an increasing number of research projects were being conducted in private veterinary practices. In these settings, researchers may not always be familiar with the regulations and the ethical best practice needed for clinical veterinary research.
The ERP reviews both prospective and retrospective research projects on cats, dogs, horses and farm animals. As well as reviewing animal-based research, the panel also reviews sociological studies involving veterinary staff.
There are currently seven available spaces on the panel, and the RCVS is looking to fill the spaces with:
The Panel is Chaired by Professor David Morton, who said: “I’ve been honoured to Chair the Ethics Review Panel for the last five years. Through my role as Chair, I have had the opportunity to work alongside some exceptional veterinary professionals and I encourage anyone with a keen interest in clinical veterinary research to apply for a position on the Panel.”
To apply, visit www.rcvs.org.uk/ethics-panel and send a completed application form and CV to ethics@rcvs.org.uk.
The deadline for applications is 5pm on Friday 16 July 2021.
The theme for the 2025 conference is how to make veterinary work sustainable, creating teams that can reliably work at their best, feel positive about work, and feel supported and valued by their team.
Keynote speaker, Amanda Oates BA (hons), MSc Strategic HRD, C.C.I.P.D. (pictured) will be talking about the concept of restorative veterinary practice, and how it relies on establishing a restorative workplace culture.
There will be three streams at the conference.
In the first stream, VetLed founder and Training Director, Dan Tipney will be joined by guest speakers to help delegates understand how they can make a difference to the way they work using human factors tools and techniques proven in human medicine and other safety-critical professions.
In the second stream, VetLed’s Community Lead, Hannah Godfrey, will be joined by human behaviour expert Katie Ford to help delegates understand themselves as humans, to acknowledge and accommodate their own needs and the needs of others, and to work better as a team.
The third stream will be hosted by VetLed Managing Director, Cat Auden, and a Chartered Psychologist, Ergonomist, and Human Factors Specialist. In this stream, delegates who are already familiar with human factors concepts will be encouraged to think big, share ideas, and shape the veterinary profession.
Tickets: £190.80
https://www.vetled.co.uk/conference
The company says AI Masses will allow veterinary professionals to analyse lesions suggestive of cancer in-clinic and with a fast turnaround.
The AI technology, which has been trained by human clinical pathologists, should enable individualised treatment outcomes earlier for more cases.
Zoetis says AI Masses only needs a single round of sample preparation and the results can, at additional cost, be supplemented with an expert review from a network of specialists through Zoetis’ Virtual Laboratory.
Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA, Global Chief Medical Officer at Zoetis said: “Waiting for results can be stressful for pet owners – even more so when it involves a cancer screening.
"Our research shows that up to 75% of pet owners find abnormal results highly stressful.1
"AI Masses is yet another point-of-care capability to deliver results in-clinic, further exemplifies Zoetis’ purpose to advance care for animals, shortening anxious wait times to allow for faster care decisions that help provide the best possible outcome.”
Pre-orders will be announced for US customers in Q2 2025.
VetSurgeon.org understands AI Masses will be coming to the UK some time in 2025.
https://www.zoetisdiagnostics.com
Reference
Avis includes over 350 articles, images, client factsheets, and diagnostic trees about avian diseases, diagnostic techniques, medications, legislation and parasitology, with a particular focus on domestic poultry.
The publishers say that content on Avis is authored and reviewed by leading avian veterinary specialists, including the St David’s Poultry Team, which has over 350 years of poultry veterinary experience.
Vetstream CEO, Dr Mark Johnston MRCVS said: We are really delighted to have worked with such a strong contribution from the St David’s Poultry Team whose experience in commercial flocks is provided to veterinarians being presented with smaller flocks.
"We have also had significant additional contributions for this launch edition of Avis across a broad range of poultry veterinary expertise.
"We want as many people as possible to take Avis for a “test flight” and so will be providing free access to all Vetlexicon subscribers for the month of June.”
The company points to research which shows that osteoarthritis can affect up to 40% of dogs 1,2 and managing the disease requires a multi-faceted 1,3, life-long, approach.
Animalcare says its osteoarthritis diary gives practices a practical, client-friendly tool to engage pet owners in their dog’s care journey, promoting adherence to treatment plans and enhancing communication between vets and pet owners.
Pet owners are asked to record three everyday activities to monitor their dog's progress, for example, its ability to get into the car, go upstairs or get up after sleeping, on a scale of 1-4.
This will allow all members of the veterinary team to understand how the patient is responding to treatment.
Kai Crawshaw, Brand Manager at Animalcare said: “This OA Diary is intended to enhance the veterinary practice’s ability to offer comprehensive, contextualised care, without increasing their workload.
"The diary supports both initial treatment plans and long-term management strategies, giving veterinary staff confidence that their patients are receiving the ongoing care they need at home.”
https://www.animalcare.co.uk/oa_diary/
References